References
- Buiting K, Kanber D, Horsthemke B, et al (2010). Imprinting of RB1( the new kid on the block). Brief Funct Genomics, 9, 347-53. https://doi.org/10.1093/bfgp/elq014
- De P, Smith BR, Leyland-Jones B (2010). Human epidermal growth factor receptor 2 testing: where are we? J Clin Oncol, 28, 4289-92 https://doi.org/10.1200/JCO.2010.29.5071
- Duman-Scheel M, Weng L, Xin SJ, et al (2002). Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E. Nature, 417, 299-304. https://doi.org/10.1038/417299a
- Eddy AA (1996). Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int, 54, S49-54.
- Gudmundsson J, Barkardottir RB, Eiriksdottir G, et al (1995). Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Brit J Cancer, 72, 696-701. https://doi.org/10.1038/bjc.1995.396
- Guran S, Bahce M, Beyan C, Korkmaz K, Yalcin A (1998). P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia. Haematologia (Budap), 29, 181-93.
- Hatada I, Inazawa J, Nakayama M, et al (1996). Genomic imprinting of human P57-KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet, 5, 783-8. https://doi.org/10.1093/hmg/5.6.783
- Karnik P, Paris M, Williams BRG, T, et al (1998). wo distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastatsis. Hum Mol Genet, 7, 895-903. https://doi.org/10.1093/hmg/7.5.895
- Kavanagh E, Joseph B (2011). The hallmarks of CDKN1C (p57, KIP2) in cancer. Biochim Biophys Acta, 1816, 50-6.
- Koepp DM, Schaefer LK, Ye X, et al (2001). Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw 7 ubiquitin ligase. Science, 294, 173-7. https://doi.org/10.1126/science.1065203
- Kondo M, Matsuoka S, Uchida K, et al (1996). Selective maternal-allele loss in human lung cancers of the maternally expressed P57-KIP2 gene at 11p15.5. Oncogene, 12, 1365-8.
- Lichy JH, Zavar M, Tsai MM, et al (1998). Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast. Am J Pathol, 153, 271-8. https://doi.org/10.1016/S0002-9440(10)65568-X
- Li Y, Millikan RC, Newman B, et al (1999). P57(KIP2) polymorphisms and breast cancer risk. Hum Genet, 104, 83-8. https://doi.org/10.1007/s004390050914
-
Matsuoka S, Edwards MC, Bai C, et al (1995).
$P57^{KIP2}$ , a structurally distinct member of the p21CIP Cdk inhibitor family is a candidate tumor suppressor gene. Gene Dev, 9, 650-62. https://doi.org/10.1101/gad.9.6.650 - Matsuoka S, Thompson J, Edwards M, et al (1996). Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor,P57-KIP2, on chromosome 11p15. P Natl Acad Sci USA, 93, 3026-30. https://doi.org/10.1073/pnas.93.7.3026
- Procter M, Suter TM, de Azambuja E, et al (2010). Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. J Clin Oncol, 28, 3422-8. https://doi.org/10.1200/JCO.2009.26.0463
- Seizinger B, Deimling A (1991). Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet, 58, 1080-96. https://doi.org/10.1159/000133722
-
Tokino T, Urano T, Furuhata T, et al (1996). Characterization of the human
$P57^{KIP2}$ gene:alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum Genet, 97, 625-31. https://doi.org/10.1007/BF02281873 - Zhang P, Liegeois N, Wong C, et al (1997). Altered cell differentiation and proliferation in mice lacking P57-KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature, 387, 151-63. https://doi.org/10.1038/387151a0
Cited by
- EGR1 decreases the malignancy of human non-small cell lung carcinoma by regulating KRT18 expression vol.4, pp.1, 2014, https://doi.org/10.1038/srep05416
- Breast cancer risk and imprinting methylation in blood vol.7, pp.1, 2015, https://doi.org/10.1186/s13148-015-0125-x
- Expression is Associated with Poor Prognosis in Human Breast Carcinoma vol.9s1, pp.1178-2234, 2015, https://doi.org/10.4137/BCBCR.S30101
- Role of P57KIP2 Immunohistochemical Expression in Histological Diagnosis of Hydatidiform Moles vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.2061
- Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells vol.389, pp.12, 2016, https://doi.org/10.1007/s00210-016-1292-9
- ) in the early mouse placenta vol.83, pp.5, 2016, https://doi.org/10.1002/mrd.22637
- and involving in p-p38 MAPK and NF-κB pathways pp.07302312, 2019, https://doi.org/10.1002/jcb.27680